「Study of the Effects of Inhibition of Epigenetic Regulators on the Proliferation of Hematological Malignant Tumor Cells」の関連論文
-
Study on the regulation of CD8+ T cell immune response through nuclear receptor RORα and REV-ERB [an abstract of entire text]
-
Genome-scale CRISPR/Cas9 screening for gemcitabine modulators in pancreatic cancer
-
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma (本文)
-
PML-RARαはMED1との結合を介して全トランス型レチノイン酸依存性の転写活性化を誘導する
-
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation
-
Molecular design of dendrimers with anionic terminal groups for delivery to various lymph node-resident cells
-
Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis
-
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Inactivation of the PD-1-dependent immunoregulation in mice exacerbates contact hypersensitivity resembling immune-related adverse events
-
Mammalian methionine adenosyltransferase 2A promotes rRNA processing and methylation of translation factors to induce translation in an mTORC1-independent manner
-
Studies on the pathological mechanism of alopecia areata in C3H/HeJ mouse model
-
Oncolytic HSV-1 in combination with lenalidomide for plasma cell neoplasms
-
Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease
-
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
-
Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1
-
Pluripotent stem cell-based therapies and their path to the clinic
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
Analyses of the Molecular Determinant of Cell Fate Induced by an Antimetabolite, Trifluridine
-
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
-
Beneficial effect of STAT3 decoy oilgodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
Simple Fluorogenic Cellular Assay for Histone Deacetylase Inhibitors Based on Split-Yellow Fluorescent Protein and Intrabodies
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Overexpression of aldolase, fructose-bisphosphate C and its association with spheroid formation in colorectal cancer
-
Study on the role of CtBP2 in pancreatic β cell
-
Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans (本文)
-
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.
-
Everolimus delayed and suppressed cytomegalovirus DNA synthesis and the spread of infection and alleviated cytomegalovirus infection
-
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
-
Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
-
Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress
-
Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress
-
Design and Functional Evaluation of Drug Delivery System Based on Dendritic Molecules and Gold Nanorods
-
Mechanisms by which Bacterial and Viral Pathogens cause Ovarian dysfunction
-
The role of vagus nerve stimulation through acetylcholine receptor during atherosclerosis progression
-
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment
-
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1
-
Identification of T cell receptors targeting a neoantigen derived from recurrently mutated FGFR3
-
Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
-
Downregulating vaccinia-related kinase 1 by luteolin suppresses ovarian cancer cell proliferation by activating the p53 signaling pathway
-
Identification and characterization of slow‑cycling cells in Ewing sarcoma
-
The lectin-like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice
-
Development of platelet replacement therapy using human induced pluripotent stem cells
-
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
-
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer.
-
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer
-
シグナル伝達抗体(Signalobody)を用いた細胞の運命制御系の開発